These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 302531)

  • 1. [Available methods to modify primary graft rejection (author's transl)].
    Prange CH; Kliems G
    Wien Klin Wochenschr; 1977 Jul; 89(14):465-74. PubMed ID: 302531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.
    Bonnefoy-Berard N; Revillard JP
    J Heart Lung Transplant; 1996 May; 15(5):435-42. PubMed ID: 8771497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 7. New approaches to immunosuppression in renal transplantation.
    Stuart FP
    Urol Clin North Am; 1976 Oct; 3(3):575-96. PubMed ID: 790732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The state of transplantation immunology from an experimental viewpoint].
    von Broen B
    Z Exp Chir; 1975; 8(4):198-214. PubMed ID: 162019
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of immunosuppression by antilymphocyte antibody.
    Taub RN
    Pathobiol Annu; 1972; 2():129-51. PubMed ID: 4149315
    [No Abstract]   [Full Text] [Related]  

  • 10. Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.
    LaCorcia G; Swistak M; Lawendowski C; Duan S; Weeden T; Nahill S; Williams JM; Dzuris JL
    Transplantation; 2009 Apr; 87(7):966-74. PubMed ID: 19352114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft rejection.
    Hunter PA
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 3)():239-42. PubMed ID: 3895610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
    Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
    J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Present and future of immunosuppressive therapy].
    Eugui EM
    Medicina (B Aires); 2000; 60(1):67-80. PubMed ID: 10835702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of action of heterologous anti-lymphocyte sera. I. "In vitro" activity and their effects on different aspects of immunity in rats.
    Kahan A; Jouanneau M; Brouilhet H; Delbarre F; Charles A
    Biomedicine; 1973 Jan; 18(1):69-77. PubMed ID: 4576461
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of skin allograft rejection by antilymphocytic serum pretreatment of the donor. Immunological preparation of the graft.
    Petrányi G; Szegedi G; Fekete B
    Acta Med Acad Sci Hung; 1971; 28(2):155-8. PubMed ID: 4948114
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 18. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The ability to influence primary rejection of xenogeneic renal transplants in the species system fox-dog by immunosuppressive agents, antisera and antigen preparations (author's transl)].
    Prange CH
    Wien Klin Wochenschr Suppl; 1980; 110():1-26. PubMed ID: 6994366
    [No Abstract]   [Full Text] [Related]  

  • 20. The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Clin Exp Immunol; 1979 Feb; 35(2):242-9. PubMed ID: 373937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.